KR102595524B1 - Platycodon grandiflorum fermented product comprising platycodon grandiflorum and rice grain syrup and method for preparing thereof - Google Patents
Platycodon grandiflorum fermented product comprising platycodon grandiflorum and rice grain syrup and method for preparing thereof Download PDFInfo
- Publication number
- KR102595524B1 KR102595524B1 KR1020230102756A KR20230102756A KR102595524B1 KR 102595524 B1 KR102595524 B1 KR 102595524B1 KR 1020230102756 A KR1020230102756 A KR 1020230102756A KR 20230102756 A KR20230102756 A KR 20230102756A KR 102595524 B1 KR102595524 B1 KR 102595524B1
- Authority
- KR
- South Korea
- Prior art keywords
- bellflower
- root
- bellflower root
- platycodin
- present
- Prior art date
Links
- 235000007164 Oryza sativa Nutrition 0.000 title claims abstract description 33
- 235000009566 rice Nutrition 0.000 title claims abstract description 33
- 239000006188 syrup Substances 0.000 title claims abstract description 25
- 235000020357 syrup Nutrition 0.000 title claims abstract description 25
- 238000000034 method Methods 0.000 title claims description 11
- 235000006753 Platycodon grandiflorum Nutrition 0.000 title claims description 9
- 244000274050 Platycodon grandiflorum Species 0.000 title 2
- 240000007594 Oryza sativa Species 0.000 title 1
- 235000013339 cereals Nutrition 0.000 title 1
- 241000209094 Oryza Species 0.000 claims abstract description 32
- GWBIYORWNUYYMZ-UHFFFAOYSA-N platycodin D Natural products CC1OC(OC2C(O)C(O)COC2OC(=O)C34CCC(C)(C)CC3C5=CCC6C7(C)CC(O)C(OC8CC(CO)C(O)C(O)C8O)C(CO)(CO)C7CCC6(C)C5(C)CC4O)C(O)C(O)C1OC9OCC(O)C(OC%10OCC(O)(CO)C%10O)C9O GWBIYORWNUYYMZ-UHFFFAOYSA-N 0.000 claims abstract description 21
- CYBWUNOAQPMRBA-NDTOZIJESA-N platycodin D Chemical compound O([C@H]1[C@@H](O)C[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@@]5([C@@H](C[C@@]4(C)[C@]3(C)CC[C@H]2C1(CO)CO)O)C(=O)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H]([C@@H]([C@@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@](O)(CO)CO2)O)[C@H](O)CO1)O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O CYBWUNOAQPMRBA-NDTOZIJESA-N 0.000 claims abstract description 21
- 238000004519 manufacturing process Methods 0.000 claims abstract description 13
- 241000332371 Abutilon x hybridum Species 0.000 claims abstract 13
- 239000000203 mixture Substances 0.000 claims description 28
- 241000894006 Bacteria Species 0.000 claims description 19
- 235000013305 food Nutrition 0.000 claims description 14
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims description 11
- 239000004480 active ingredient Substances 0.000 claims description 9
- 240000003582 Platycodon grandiflorus Species 0.000 claims description 7
- 108090000790 Enzymes Proteins 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 6
- 241000589565 Flavobacterium Species 0.000 claims description 6
- 229940088598 enzyme Drugs 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 4
- 108010059892 Cellulase Proteins 0.000 claims description 3
- 108010059820 Polygalacturonase Proteins 0.000 claims description 3
- 229940106157 cellulase Drugs 0.000 claims description 3
- 235000019640 taste Nutrition 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 7
- 230000002829 reductive effect Effects 0.000 abstract description 5
- 241000703121 Campanula rotundifolia Species 0.000 description 74
- 230000000052 comparative effect Effects 0.000 description 25
- 230000036541 health Effects 0.000 description 11
- 239000000284 extract Substances 0.000 description 10
- 235000013376 functional food Nutrition 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- APTNOIWSCDBIAS-UHFFFAOYSA-N 5,10,11-trihydroxy-9,9-bis(hydroxymethyl)-2,2,6a,6b,12a-pentamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid Chemical compound C1C(O)C(O)C(CO)(CO)C2CCC3(C)C4(C)CC(O)C5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C APTNOIWSCDBIAS-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 230000003419 expectorant effect Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000000954 anitussive effect Effects 0.000 description 3
- 230000001078 anti-cholinergic effect Effects 0.000 description 3
- 229940124584 antitussives Drugs 0.000 description 3
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical group 0.000 description 3
- 235000017709 saponins Nutrition 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 206010012438 Dermatitis atopic Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000003579 anti-obesity Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 201000008937 atopic dermatitis Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000021096 natural sweeteners Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 206010044008 tonsillitis Diseases 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- CNHZRRBWLMSLDX-WNHLAMKZSA-N 2''O-acetylplatycodin D Chemical compound O([C@H]1[C@@H](O)C[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@@]5([C@@H](C[C@@]4(C)[C@]3(C)CC[C@H]2C1(CO)CO)O)C(=O)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H]([C@@H]([C@@H](O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@](O)(CO)CO2)O)[C@H](O)CO1)O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O CNHZRRBWLMSLDX-WNHLAMKZSA-N 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000123667 Campanula Species 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- -1 It consists of C Natural products 0.000 description 1
- 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 description 1
- 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 description 1
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 102000003923 Protein Kinase C Human genes 0.000 description 1
- 108090000315 Protein Kinase C Proteins 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- KGGGRGBDMBZXKF-UHFFFAOYSA-N Virganreagenin G Natural products C1C(O)C(O)C(C)(CO)C2CCC3(C)C4(C)CC(O)C5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C KGGGRGBDMBZXKF-UHFFFAOYSA-N 0.000 description 1
- BDCUGHMNUOTFKX-YJGMJMKZSA-N [(2s,3r,4s,5s)-3-[(2s,3r,4s,5r,6s)-5-[(2s,3r,4s,5r)-4-[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl] (4ar,5r,6ar,6as,6br,8ar,9r,10r,11s,12ar,14bs)-5,11-dihy Polymers O([C@H]1[C@@H](O)C[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@@]5([C@@H](C[C@@]4(C)[C@]3(C)CC[C@H]2[C@@]1(CO)C)O)C(=O)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H]([C@@H]([C@@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@](O)(CO)CO2)O)[C@H](O)CO1)O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O BDCUGHMNUOTFKX-YJGMJMKZSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 230000001164 bioregulatory effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000003874 central nervous system depressant Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
- 229960002986 dinoprostone Drugs 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000007603 infrared drying Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 230000008533 pain sensitivity Effects 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 229930189407 platycodin Natural products 0.000 description 1
- IVDSKBGNLNNRFN-UHFFFAOYSA-N platycodin A Natural products CC1OC(OC2C(O)C(O)COC2OC(=O)C34CCC(C)(C)CC3C5=CCC6C7(C)CC(O)C(OC8CC(CO)C(O)C(O)C8O)C(CO)(CO)C7CCC6(C)C5(C)CC4O)C(OC(=O)C)C(O)C1OC9OCC(O)C(OC%10OCC(O)(CO)C%10O)C9O IVDSKBGNLNNRFN-UHFFFAOYSA-N 0.000 description 1
- 208000008423 pleurisy Diseases 0.000 description 1
- BDCUGHMNUOTFKX-DDRWPPTGSA-N polygalacin D Polymers O([C@H]1[C@@H](O)C[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@@]5([C@@H](C[C@@]4(C)[C@]3(C)CC[C@H]2[C@]1(CO)C)O)C(=O)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H]([C@@H]([C@@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@](O)(CO)CO2)O)[C@H](O)CO1)O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O BDCUGHMNUOTFKX-DDRWPPTGSA-N 0.000 description 1
- DJPJACADAIGMKF-CTELNEMLSA-N polygalacin-D Natural products O=C(O[C@H]1[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@H]3[C@H](O)[C@@H](O[C@@]4(O)[C@H](O)[C@@](O)(CO)CO4)[C@H](O)CO3)[C@H](C)O2)[C@@H](O)[C@@H](O)CO1)[C@@]12[C@H](O)C[C@@]3(C)[C@@]4(C)[C@@H]([C@]5(C)[C@H]([C@@](CO)(C)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O)C5)CC4)CC=C3[C@@H]1CC(C)(C)CC2 DJPJACADAIGMKF-CTELNEMLSA-N 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/20—Malt products
- A23L7/25—Fermentation of cereal malt or of cereal by malting
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/50—Concentrating, enriching or enhancing in functional factors
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명은 도라지 및 쌀조청을 포함하는 도라지 발효물 및 이의 제조 방법에 관한 것으로, 본 발명의 도라지 및 쌀조청을 포함하는 도라지 발효물 및 이의 제조 방법에 따르면, 도라지의 쓴맛 또는 아린 맛을 저감하고, 플라티코딘 D 함량이 증가된 효과를 얻을 수 있다.The present invention relates to a fermented bellflower root containing bellflower root and rice syrup and a method for producing the same. According to the fermented bellflower root product containing bellflower root and rice syrup and a method for producing the same, the bitter or acrid taste of bellflower root is reduced, , the effect of increased platycodin D content can be obtained.
Description
아래 실시예들은 도라지 및 쌀조청을 포함하는 도라지 발효물 및 이의 제조 방법에 관한 것이다.The examples below relate to bellflower fermented products including bellflower root and rice syrup and methods for producing the same.
도라지(Platycodon grandiflorum)는 초롱꽃과의 쌍떡잎식물로 여러해살이풀이며, 전체에 털이 없고 뿌리는 비대하고, 줄기는 하나 또는 모여서 나며, 전국 각지 산야에서 자생한다. 우리나라에서는 주로 식용으로 많이 쓰였으나, 약리 성분 및 약리학적인 기능을 인정받아 식용뿐만 아니라 건강기능 식품으로서도 소비량이 증가하면서 그 재배 면적이 확대되고 있다. 한방에서는 뿌리 또는 주피를 제거하여 길경이라는 약재를 만들 때 사용하는데, 이 약재는 진해 및 거담에 이용되며 추출액은 진정, 해열, 진통, 진해, 거담, 혈당 강하, 콜레스테롤 대사 개선, 항콜린, 항암 작용 및 위산분비 억제 효과가 있다. 도라지는 당질, 칼슘과 철분 등이 풍부하게 들어있는 알칼리성 식품으로 사포닌(saponin)을 주요 약리 성분으로 한다. 그러나 이러한 도라지는 장기간 보관이 곤란하여 채취한 후 바로 섭취해야 하며, 특유의 냄새와 도라지 자체의 쓴맛 또는 아린 맛 때문에 소비자에게 거부감을 줄 수 있다. 이에 도라지의 쓴맛 또는 아린 맛을 저감하고 도라지의 유용성분을 용이하게 섭취할 수 있는 도라지의 제조방법이 필요한 실정이다.Bellflower ( Platycodon grandiflorum ) is a dicotyledonous plant of the Campanula family and is a perennial herb. It has hairless roots, has enlarged roots, grows singly or in clusters, and grows wild in mountains and fields across the country. In Korea, it was mainly used for food, but its medicinal properties and pharmacological functions have been recognized, and its cultivation area is expanding as its consumption increases not only as an edible but also as a health functional food. In oriental medicine, the root or pericarp is removed and used to make a herb called Gilgyeong. This herb is used for antitussive and expectorant properties. The extract has sedative, antipyretic, analgesic, antitussive, expectorant, blood sugar lowering, cholesterol metabolism improvement, anticholinergic, and anticancer effects. It has an effect of suppressing gastric acid secretion. Bellflower root is an alkaline food rich in carbohydrates, calcium, and iron, and its main pharmacological ingredient is saponin. However, these bellflowers are difficult to store for a long period of time, so they must be consumed immediately after collection, and the unique smell and the bitter or sore taste of the bellflowers themselves can be repulsive to consumers. Accordingly, there is a need for a method of manufacturing bellflower root that can reduce the bitter or acrid taste of bellflower root and allow easy intake of useful components of bellflower root.
아래 실시예들은 상기와 같은 문제점을 해결하기 위하여 안출된 것으로서, 본 발명은 도라지의 쓴맛 또는 아린 맛을 저감하고, 플라티코딘 D 함량이 증가된 도라지 및 쌀조청을 포함하는 도라지 발효물 및 이의 제조 방법을 제공하는 것을 목적으로 한다.The examples below were devised to solve the above problems, and the present invention reduces the bitter or acrid taste of bellflower root and includes bellflower root and rice syrup with increased platycodin D content, and the preparation thereof. The purpose is to provide a method.
전술한 본 발명의 목적을 달성하기 위하여, 본 발명의 일 구현예는 도라지 및 쌀조청을 혼합하여 도라지 혼합물을 얻는 단계; 상기 도라지 혼합물에 효소를 처리하고 균을 접종하여 발효함으로써 도라지 발효물을 얻는 단계; 및 상기 도라지 발효물을 여과 및 농축하여 당 함량과 점도를 증가시키는 단계;를 포함하며, 상기 균은 쌀누룩균 또는 플라보박테리움(Flavobacterium)인, 플라티코딘 D 함량이 증가된 도라지청의 제조 방법을 제공한다.In order to achieve the object of the present invention described above, one embodiment of the present invention includes the steps of mixing bellflower root and rice syrup to obtain a balloon flower mixture; Obtaining a fermented bellflower product by treating the bellflower mixture with an enzyme, inoculating it with bacteria, and fermenting it; And filtering and concentrating the bellflower fermented product to increase the sugar content and viscosity, wherein the bacteria are rice malt bacteria or Flavobacterium, producing bellflower root with increased platycodin D content. Provides a method.
본 발명의 일 구현예는 상기 제조 방법에 의해 제조된 도라지청을 포함하며, 상기 도라지청에 함유된 플라티코딘 D를 유효성분으로 포함하며, 상기 플라티코딘 D는 조성물 총 중량에 대하여 0.001 내지 50 중량%로 포함되며, 40 내지 70 Brix의 당도 및 500 내지 2000 poise의 점도를 갖는, 식품 조성물을 제공한다.One embodiment of the present invention includes bellflower root produced by the above production method, and includes platycodin D contained in the bellflower root as an active ingredient, wherein the platycodin D is present in an amount of 0.001 to 0.001 based on the total weight of the composition. It provides a food composition that is contained at 50% by weight and has a sugar content of 40 to 70 Brix and a viscosity of 500 to 2000 poise.
본 발명의 도라지 및 쌀조청을 포함하는 도라지 발효물 및 이의 제조 방법에 따르면, 도라지의 쓴맛 또는 아린 맛을 저감하고, 플라티코딘 D 함량이 증가된 효과를 얻을 수 있다. According to the fermented bellflower root product containing bellflower root and rice syrup of the present invention and the method for producing the same, the bitter or acrid taste of bellflower root can be reduced and the platycodin D content increased.
이하에서, 첨부된 도면을 참조하여 실시예들을 상세하게 설명한다. 그러나, 실시예들에는 다양한 변경이 가해질 수 있어서 특허출원의 권리 범위가 이러한 실시예들에 의해 제한되거나 한정되는 것은 아니다. 실시예들에 대한 모든 변경, 균등물 내지 대체물이 권리 범위에 포함되는 것으로 이해되어야 한다.Hereinafter, embodiments will be described in detail with reference to the attached drawings. However, various changes can be made to the embodiments, so the scope of the patent application is not limited or limited by these embodiments. It should be understood that all changes, equivalents, or substitutes for the embodiments are included in the scope of rights.
실시예들에 대한 특정한 구조적 또는 기능적 설명들은 단지 예시를 위한 목적으로 개시된 것으로서, 다양한 형태로 변경되어 실시될 수 있다. 따라서, 실시예들은 특정한 개시형태로 한정되는 것이 아니며, 본 명세서의 범위는 기술적 사상에 포함되는 변경, 균등물, 또는 대체물을 포함한다.Specific structural or functional descriptions of the embodiments are disclosed for illustrative purposes only and may be modified and implemented in various forms. Accordingly, the embodiments are not limited to the specific disclosed form, and the scope of the present specification includes changes, equivalents, or substitutes included in the technical spirit.
제1 또는 제2 등의 용어를 다양한 구성요소들을 설명하는데 사용될 수 있지만, 이런 용어들은 하나의 구성요소를 다른 구성요소로부터 구별하는 목적으로만 해석되어야 한다. 예를 들어, 제1 구성요소는 제2 구성요소로 명명될 수 있고, 유사하게 제2 구성요소는 제1 구성요소로도 명명될 수 있다.Terms such as first or second may be used to describe various components, but these terms should be interpreted only for the purpose of distinguishing one component from another component. For example, a first component may be named a second component, and similarly, the second component may also be named a first component.
어떤 구성요소가 다른 구성요소에 “연결되어” 있다고 언급된 때에는, 그 다른 구성요소에 직접적으로 연결되어 있거나 또는 접속되어 있을 수도 있지만, 중간에 다른 구성요소가 존재할 수도 있다고 이해되어야 할 것이다.When a component is referred to as being “connected” to another component, it should be understood that it may be directly connected or connected to the other component, but that other components may exist in between.
실시예에서 사용한 용어는 단지 설명을 목적으로 사용된 것으로, 한정하려는 의도로 해석되어서는 안 된다. 단수의 표현은 문맥상 명백하게 다르게 뜻하지 않는 한, 복수의 표현을 포함한다. 본 명세서에서, “포함하다” 또는 "“가지다” 등의 용어는 명세서 상에 기재된 특징, 숫자, 단계, 동작, 구성요소, 부품 또는 이들을 조합한 것이 존재함을 지정하려는 것이지, 하나 또는 그 이상의 다른 특징들이나 숫자, 단계, 동작, 구성요소, 부품 또는 이들을 조합한 것들의 존재 또는 부가 가능성을 미리 배제하지 않는 것으로 이해되어야 한다.The terms used in the examples are for descriptive purposes only and should not be construed as limiting. Singular expressions include plural expressions unless the context clearly dictates otherwise. In this specification, terms such as “comprise” or “have” are intended to designate the presence of features, numbers, steps, operations, components, parts, or combinations thereof described in the specification, but are intended to indicate the presence of one or more other It should be understood that this does not exclude in advance the presence or addition of features, numbers, steps, operations, components, parts, or combinations thereof.
다르게 정의되지 않는 한, 기술적이거나 과학적인 용어를 포함해서 여기서 사용되는 모든 용어들은 실시예가 속하는 기술 분야에서 통상의 지식을 가진 자에 의해 일반적으로 이해되는 것과 동일한 의미를 가지고 있다. 일반적으로 사용되는 사전에 정의되어 있는 것과 같은 용어들은 관련 기술의 문맥 상 가지는 의미와 일치하는 의미를 가지는 것으로 해석되어야 하며, 본 출원에서 명백하게 정의하지 않는 한, 이상적이거나 과도하게 형식적인 의미로 해석되지 않는다.Unless otherwise defined, all terms used herein, including technical or scientific terms, have the same meaning as generally understood by a person of ordinary skill in the technical field to which the embodiments belong. Terms defined in commonly used dictionaries should be interpreted as having a meaning consistent with the meaning in the context of the related technology, and unless explicitly defined in the present application, should not be interpreted in an ideal or excessively formal sense. No.
본 발명의 이점 및 특징, 그리고 그것들을 달성하는 방법은 첨부되는 도면과 함께 상세하게 후술되어 있는 실시예들을 참조하면 명확해질 것이다. 그러나 본 발명은 이하에서 개시되는 실시예들에 한정되는 것이 아니라 서로 다른 다양한 형태로 구현될 것이며, 단지 본 실시예들은 본 발명의 개시가 완전하도록 하며, 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 발명의 범주를 완전하게 알려주기 위해 제공되는 것이며, 본 발명은 청구항의 범주에 의해 정의될 뿐이다.The advantages and features of the present invention and methods for achieving them will become clear by referring to the embodiments described in detail below along with the accompanying drawings. However, the present invention is not limited to the embodiments disclosed below and will be implemented in various different forms. The present embodiments only serve to ensure that the disclosure of the present invention is complete and that common knowledge in the technical field to which the present invention pertains is not limited. It is provided to fully inform those who have the scope of the invention, and the present invention is only defined by the scope of the claims.
본 발명의 실시예들에서, 별도로 다르게 정의되지 않는 한, 기술적이거나 과학적인 용어를 포함해서 여기서 사용되는 모든 용어들은 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자에 의해 일반적으로 이해되는 것과 동일한 의미를 가지고 있다. 일반적으로 사용되는 사전에 정의되어 있는 것과 같은 용어들은 관련 기술의 문맥 상 가지는 의미와 일치하는 의미를 가지는 것으로 해석되어야 하며, 본 발명의 실시예에서 명백하게 정의하지 않는 한, 이상적이거나 과도하게 형식적인 의미로 해석되지 않는다.In the embodiments of the present invention, unless otherwise defined, all terms used herein, including technical or scientific terms, are the same as those commonly understood by a person of ordinary skill in the technical field to which the present invention pertains. It has meaning. Terms defined in commonly used dictionaries should be interpreted as having a meaning consistent with the meaning in the context of the related technology, and unless clearly defined in the embodiments of the present invention, have an ideal or excessively formal meaning. It is not interpreted as
본 발명의 실시예를 설명하기 위한 도면에 개시된 형상, 크기, 비율, 각도, 개수 등은 예시적인 것이므로 본 발명이 도시된 사항에 한정되는 것은 아니다. 또한, 본 발명을 설명함에 있어서, 관련된 공지 기술에 대한 구체적인 설명이 본 발명의 요지를 불필요하게 흐릴 수 있다고 판단되는 경우 그 상세한 설명은 생략한다. 본 명세서 상에서 언급된 ‘포함한다’, ‘갖는다’, ‘이루어진다’ 등이 사용되는 경우 ‘~만’이 사용되지 않는 이상 다른 부분이 추가될 수 있다. 구성 요소를 단수로 표현한 경우에 특별히 명시적인 기재 사항이 없는 한 복수를 포함하는 경우를 포함한다.The shapes, sizes, proportions, angles, numbers, etc. disclosed in the drawings for explaining embodiments of the present invention are illustrative, and the present invention is not limited to the matters shown. Additionally, in describing the present invention, if it is determined that a detailed description of related known technologies may unnecessarily obscure the gist of the present invention, the detailed description will be omitted. When ‘includes’, ‘has’, ‘consists of’, etc. mentioned in this specification are used, other parts may be added unless ‘only’ is used. When a component is expressed in the singular, the plural is included unless specifically stated otherwise.
구성 요소를 해석함에 있어서, 별도의 명시적 기재가 없더라도 오차 범위를 포함하는 것으로 해석한다.When interpreting a component, it is interpreted to include the margin of error even if there is no separate explicit description.
도면에서 나타난 각 구성의 크기 및 두께는 설명의 편의를 위해 도시된 것이며, 본 발명이 도시된 구성의 크기 및 두께에 반드시 한정되는 것은 아니다.The size and thickness of each component shown in the drawings are shown for convenience of explanation, and the present invention is not necessarily limited to the size and thickness of the components shown.
본 발명의 여러 실시예들의 각각 특징들이 부분적으로 또는 전체적으로 서로 결합 또는 조합 가능하며, 당업자가 충분히 이해할 수 있듯이 기술적으로 다양한 연동 및 구동이 가능하며, 각 실시예들이 서로에 대하여 독립적으로 실시 가능할 수도 있고 연관 관계로 함께 실시 가능할 수도 있다.Each feature of the various embodiments of the present invention can be partially or fully combined or combined with each other, and as can be fully understood by those skilled in the art, various technical interconnections and operations are possible, and each embodiment may be implemented independently of each other. It may be possible to conduct them together due to a related relationship.
본 발명에서 용어, “추출물(extract)”은 천연물로부터 분리된 활성 성분을 의미하며, 물, 유기 용매, 또는 이들의 혼합 용매를 이용하는 추출 과정으로 획득할 수 있으며, 추출액, 이의 건조 분말 또는 이를 이용하여 제형화된 모든 형태를 포함한다. 추출한 액은 바로 사용하거나 또는 농축 및/또는 건조하여 “분말(powder)”로서 사용할 수 있다. 유기 용매를 사용하여 추출하는 경우, 메탄올, 에탄올, 이소프로판올, 부탄올, 에틸렌, 아세톤, 헥산, 에테르, 클로로포름, 에틸아세테이트, 부틸아세테이트, 디클로로메탄, N,N-디메틸포름아미드(DMF), 디메틸설폭사이드(DMSO), 1,3-부틸렌글리콜, 프로필렌글리콜 또는 이들의 혼합용매인 유기용매를 사용하며 유효 성분이 파괴되지 않거나 최소화된 조건에서 실온 또는 가온하여 추출할 수 있다. 추출하는 유기용매에 따라 약재의 유효성분의 추출 정도와 손실 정도가 차이날 수 있으므로, 알맞은 유기용매를 선택하여 사용하도록 한다. 추출방법은 특별히 제한되지 않고, 예를 들어 열수 추출, 냉침 추출, 초음파 추출 및 환류 추출 등이 있다.In the present invention, the term “extract” refers to an active ingredient isolated from a natural product, and can be obtained through an extraction process using water, an organic solvent, or a mixed solvent thereof, and can be obtained by using an extract, a dry powder thereof, or This includes all formulated forms. The extracted liquid can be used directly or concentrated and/or dried and used as a “powder.” When extracting using organic solvents, methanol, ethanol, isopropanol, butanol, ethylene, acetone, hexane, ether, chloroform, ethyl acetate, butyl acetate, dichloromethane, N,N-dimethylformamide (DMF), dimethyl sulfoxide An organic solvent such as (DMSO), 1,3-butylene glycol, propylene glycol, or a mixed solvent thereof can be used, and the active ingredient can be extracted at room temperature or by heating under conditions where it is not destroyed or minimized. The degree of extraction and loss of the active ingredient of the herbal medicine may vary depending on the organic solvent being extracted, so select and use an appropriate organic solvent. The extraction method is not particularly limited and includes, for example, hot water extraction, cold needle extraction, ultrasonic extraction, and reflux extraction.
상기 용매 추출물은 부유하는 고체 입자를 제거하기 위하여 추출물을 여과시키는 단계를 추가로 포함할 수 있다. 면, 나일론 등을 이용하여 입자를 걸러내거나 한외여과, 냉동여과법, 원심분리법 등을 사용할 수 있으나, 이에 제한되지 않는다. 추출액을 농축할 경우에는, 감압농축, 역삼투압 농축 등의 방법이 사용될 수 있다. 농축 후 건조 단계는 동결건조, 진공건조, 열풍건조, 분무건조, 감압건조, 포말건조, 고주파건조, 적외선건조 등을 포함하나 이에 제한되지 않는다.The solvent extract may further include filtering the extract to remove floating solid particles. Particles may be filtered using cotton, nylon, etc., or ultrafiltration, cryofiltration, centrifugation, etc. may be used, but are not limited thereto. When concentrating the extract, methods such as reduced pressure concentration and reverse osmosis concentration may be used. The drying step after concentration includes, but is not limited to, freeze drying, vacuum drying, hot air drying, spray drying, reduced pressure drying, foam drying, high frequency drying, and infrared drying.
이하, 본 발명에 대해서 실시예 및 도면을 참조하여 구체적으로 설명한다. 그러나, 하기 실시예 및 도면에 의하여 본 발명이 한정되지 아니함은 자명하다.Hereinafter, the present invention will be described in detail with reference to examples and drawings. However, it is obvious that the present invention is not limited to the following examples and drawings.
도라지청의 제조 방법How to make bellflower root
일 측면에서, 본 발명은 도라지 및 쌀조청을 혼합하여 도라지 혼합물을 얻는 단계; 상기 도라지 혼합물에 효소를 처리하고 균을 접종하여 발효함으로써 도라지 발효물을 얻는 단계; 및 상기 도라지 발효물을 여과 및 농축하여 당 함량과 점도를 증가시키는 단계;를 포함하며, 상기 균은 쌀누룩균 또는 플라보박테리움(Flavobacterium)인, 플라티코딘 D 함량이 증가된 도라지청의 제조 방법을 제공한다.In one aspect, the present invention includes the steps of mixing bellflower root and rice syrup to obtain a bellflower root mixture; Obtaining a fermented bellflower product by treating the bellflower mixture with an enzyme, inoculating it with bacteria, and fermenting it; And filtering and concentrating the bellflower fermented product to increase the sugar content and viscosity, wherein the bacteria are rice malt bacteria or Flavobacterium, producing bellflower root with increased platycodin D content. Provides a method.
도라지에 함유된 사포닌은 플라티코디제닌(platycodigenin)을 아글리콘(aglycone)으로 하는 플라티코딘(platycodin) A, C, D, D2, D3, 플라티코디제닌 산(platycodigenic acid) A1 내지 A5, C, 폴리갈라시 산(polygalacic acid), 폴리갈라신(polygalacin) D, D2, 플라티코디제닌, 플라티코디젠-3-O-β-D-글루코피라노시드 등으로 이루어진다. 상기 사포닌 성분은 진해, 거담작용, 중추신경억제작용(진정, 진통, 해열), 혈관을 확장하여 혈압을 낮추는 항 콜린작용, 혈당강하, 콜레스테롤 대사 개선, 항콜린, 항암작용, 위산분배 억제효과, 항궤양작용, 배농, 화농성 종기, 천식 및 폐결핵의 거담제로서 늑막염 등에도 효과가 있는 것으로 알려져 있다. 또한, 플라티코딘 D는 항염증, 항비만, 항아토피 등 다양한 효과가 있는 것으로 보고되어 있고, 대한민국 등록특허 제10-1516063호는 플라티코딘 D가 함유된 도라지 추출물을 유효성분으로 포함하는 피부보습용 화장료 조성물을 개시하고 있다. 플라티코딘 D를 척수에 투여하면 GABA알파, GABA베타, NMDA 및 non-NMDA 수용체에 의해 통증에 대한 감수성이 현저하게 낮아지고, 플라티코딘 D는 단백질 키나제 C가 활성화된 랫트의 복막대식세포에서 프로스타글란딘 E2의 합성을 억제하는 것으로 알려져 있다.Saponins contained in bellflower root include platycodin A, C, D, D2, D3, platycodigenin A1 to A5, which has platycodigenin as an aglycone, It consists of C, polygalacic acid, polygalacin D, D2, platycodegenin, platycodegen-3-O-β-D-glucopyranoside, etc. The saponin component has an antitussive, expectorant effect, central nervous system depressant effect (sedation, analgesic, antipyretic), anticholinergic effect that lowers blood pressure by dilating blood vessels, lowering blood sugar, improving cholesterol metabolism, anticholinergic, anticancer effect, gastric acid distribution inhibitory effect, and antibacterial effect. It is known to be effective in pleurisy as an expectorant for ulcers, drainage, purulent boils, asthma and pulmonary tuberculosis. In addition, platycodin D is reported to have various effects such as anti-inflammatory, anti-obesity, and anti-atopic dermatitis, and Korea Patent Registration No. 10-1516063 discloses a skin treatment containing bellflower root extract containing platycodin D as an active ingredient. A moisturizing cosmetic composition is disclosed. When platycodin D is administered to the spinal cord, pain sensitivity is significantly lowered by GABA alpha, GABA beta, NMDA, and non-NMDA receptors, and platycodin D is expressed in rat peritoneal macrophages with activated protein kinase C. It is known to inhibit the synthesis of prostaglandin E2.
일 구현예에서, 상기 도라지는 백도라지, 흑도라지, 약도라지 및 먹도라지로 이루어진 군으로부터 선택되는 하나 이상이다. 일 구현예에서, 상기 도라지는 약도라지이다. 상기 약도라지는 폐열, 편도염, 설사에 효과를 제공하여 면역기능이 저하되는 것을 억제해준다. 또한, 상기 약도라지는 기침, 가래, 편도선염, 천식 등과 더불어, 기관지 및 폐 기능 향상에 효과적이다. 일 구현예에서, 상기 약도라지는 3년근 우량 도라지이다.In one embodiment, the bellflower is one or more selected from the group consisting of white bellflower, black bellflower, weak bellflower, and black bellflower. In one embodiment, the bellflower is Yakdoraji. The medicinal bellflower root provides effects on lung fever, tonsillitis, and diarrhea and suppresses the decline in immune function. In addition, the medicinal bellflower root is effective in improving bronchial and lung function along with cough, phlegm, tonsillitis, asthma, etc. In one embodiment, the medicinal bellflower is a 3-year old bellflower.
상기 쌀조청은 쌀의 전분을 엿기름으로 당화시켜 농축시킨 것으로 위를 보호하고 소화에 도움을 주는 천연 감미료이며, 설탕은 최소한의 양으로 조절함으로써 맛과 식욕을 돋우고 음료의 방부제 역할과 함께 점성을 높여준다.The rice syrup is a natural sweetener that is made by saccharifying rice starch into malt and concentrating it, and is a natural sweetener that protects the stomach and aids digestion. By adjusting the sugar to a minimum amount, it enhances taste and appetite, acts as a preservative for the drink, and increases viscosity. give.
일 구현예에서, 상기 도라지 혼합물을 얻는 단계에 있어서, 백출, 백복령, 당귀, 천궁, 오미자, 진피, 감초, 작약 및 맥문동을 포함하는 한약재를 추가로 혼합한다. In one embodiment, in the step of obtaining the balloon flower mixture, herbal medicines including Baekchul, Baekbokryeong, Angelica root, Cheongung, Schisandra chinensis, Derpi, licorice, peony, and Macmundong are additionally mixed.
일 구현예에서, 상기 도라지 및 쌀조청은 2 내지 10 : 1의 중량비로 혼합된다.In one embodiment, the bellflower root and rice syrup are mixed at a weight ratio of 2 to 10:1.
일 구현예에서, 상기 균은 쌀누룩균 또는 플라보박테리움(Flavobacterium)이다. 본 발명자들은 도라지청을 제조할 때, 유산균이 아닌 쌀누룩균 또는 플라보박테리움(Flavobacterium)으로 발효 분해를 수행할 경우, 특유의 냄새와 도라지 자체의 쓴맛 또는 아린 맛을 잡아내는 동시에, 플라티코딘 D도 높은 함량으로 추출할 수 있다는 것을 지견하여 본 발명을 완성하였다. In one embodiment, the bacteria is Rice Aspergillus or Flavobacterium. When producing bellflower root, the present inventors performed fermentation and decomposition with rice malt bacteria or Flavobacterium, rather than lactic acid bacteria, to capture the unique odor and the bitter or acrid taste of bellflower root itself, while also containing platycodin. The present invention was completed by discovering that D can be extracted at a high content.
일 구현예에서, 상기 쌀조청 및 균은 100 : 0.1 내지 0.5의 중량비로 혼합된다.In one embodiment, the rice syrup and bacteria are mixed at a weight ratio of 100:0.1 to 0.5.
일 구현예에서, 상기 효소는 셀룰라아제(cellulase) 및 폴리갈락투로나아제(polygalacturonase)일 수 있으나, 이에 제한되지 않는다. 상기 효소는 동시에 또는 순차적으로 처리될 수 있으나, 이에 제한되지 않는다.In one embodiment, the enzyme may be cellulase and polygalacturonase, but is not limited thereto. The enzymes may be processed simultaneously or sequentially, but are not limited thereto.
상기 플라티코딘 D(Platycodin D)는 하기 화학식 1로 표시된다.The Platycodin D is represented by the following formula (1).
[화학식1][Formula 1]
상기 플라티코딘 D는 항염증, 항비만, 항아토피 등 다양한 효과가 있는 것으로 보고되어 있고, 코로나 바이러스가 사람 세포와 융합하는 과정을 차단해 감염을 막을 수 있으며, 다양한 질병의 예방 차원에서 꾸준히 복용하면 면역력 강화의 효과를 볼 수 있다. 또한, 상기 플라티코딘 D는 간 지방산을 억제하고 지방간을 극복하게 도와주며, 나아가, 약물학서적 신농본초경에 두려움을 치료한다고 기록되어 있다.Platicodin D is reported to have various effects such as anti-inflammatory, anti-obesity, and anti-atopic dermatitis, and can prevent infection by blocking the process of the coronavirus merging with human cells. It is taken consistently to prevent various diseases. If you do this, you can see the effect of strengthening your immunity. In addition, the platycodin D suppresses liver fatty acids and helps overcome fatty liver disease, and furthermore, it is recorded in the pharmacology book Shennong Herbal Medicine to treat fear.
일 구현예에서, 상기 여과에 의하여 고액 분리된다. 일 구현예에서, 상기 농축 단계는 40℃ 내지 50℃의 온도로 10분 내지 2시간 동안 가열하여 수행된다. In one embodiment, solid and liquid are separated by the filtration. In one embodiment, the concentration step is performed by heating at a temperature of 40°C to 50°C for 10 minutes to 2 hours.
일 구현예에서, 상기 식품 조성물은 40 내지 70 Brix의 당도 및 500 내지 2000 poise의 점도를 갖는다.In one embodiment, the food composition has a sweetness of 40 to 70 Brix and a viscosity of 500 to 2000 poise.
도라지청을 포함하는 건강기능 식품 조성물Health functional food composition containing bellflower root
일 측면에서, 본 발명은 상기 제조 방법에 의해 제조된 도라지청을 포함하며, 상기 도라지청에 함유된 플라티코딘 D를 유효성분으로 포함하며, 상기 플라티코딘 D는 조성물 총 중량에 대하여 0.001 내지 50 중량%로 포함되며, 40 내지 70 Brix의 당도 및 500 내지 2000 poise의 점도를 갖는, 식품 조성물을 제공한다.In one aspect, the present invention includes bellflower root produced by the above production method, and includes platycodin D contained in the bellflower root as an active ingredient, wherein the platycodin D is present in an amount of 0.001 to 0.001 based on the total weight of the composition. It provides a food composition that is contained at 50% by weight and has a sugar content of 40 to 70 Brix and a viscosity of 500 to 2000 poise.
일 구현예에서, 상기 식품 조성물에 있어서, 상기 플라티코딘 D는 조성물 총 중량에 대하여 0.001 내지 50 중량%로 포함된다. 보다 구체적으로, 상기 플라티코딘 D는 조성물 총 중량에 대하여 0.001 중량% 이상, 0.01 중량% 이상, 0.1 중량% 이상, 1 중량% 이상, 10 중량% 이상, 15 중량% 이상, 20 중량% 이상, 25 중량% 이상, 30 중량% 이상; 50 중량% 이하, 45 중량% 이하, 40 중량% 이하, 35 중량% 이하, 30 중량% 이하의 양으로 함유된다.In one embodiment, in the food composition, the platycodin D is included in an amount of 0.001 to 50% by weight based on the total weight of the composition. More specifically, the platycodin D is present in an amount of at least 0.001% by weight, at least 0.01% by weight, at least 0.1% by weight, at least 1% by weight, at least 10% by weight, at least 15% by weight, at least 20% by weight, 25% by weight or more, 30% by weight or more; It is contained in an amount of 50% by weight or less, 45% by weight or less, 40% by weight or less, 35% by weight or less, and 30% by weight or less.
삭제delete
상기 “예방”은 상기 조성물의 투여로 질병을 억제 또는 지연시키는 모든 행위를 의미한다. 상기 “개선”은 상태와 관련된 파라미터, 예를 들면 증상의 정도를 적어도 감소시키는 모든 행위를 의미한다.The “prevention” refers to any action that suppresses or delays disease by administering the composition. The term “improvement” refers to any action that at least reduces the severity of parameters related to the condition, such as symptoms.
본 개시의 일 구현예에 따르면, 상기 조성물은 건강기능 식품 조성물이다. 일 구현예에서, 상기 식품 조성물을 포함시켜 분말, 과립, 환, 정제, 캡슐 또는 음료 형태 중 어느 하나로 이루어지는 건강 기능식품으로 제조할 수 있다. 제조 방식은 굽는 방식, 원적외선 방식을 이용할 수 있으나, 이에 제한되는 것은 아니다.According to one embodiment of the present disclosure, the composition is a health functional food composition. In one embodiment, the food composition can be included to produce a health functional food in any of powder, granule, pill, tablet, capsule, or beverage form. The manufacturing method may use a baking method or a far-infrared method, but is not limited thereto.
상기 “건강기능 식품”은 건강보조의 목적으로 특정 성분을 원료로 하거나 원료에 들어있는 특정 성분을 추출, 농축, 정제, 혼합 등의 방법으로 제조, 가공한 식품을 의마하며, 상기 성분에 의하여 생체 방어, 등 생체조절 기능을 생체에 대하여 충분히 발휘할 수 있도록 설계되고 가공된 식품을 의미하는 것으로서, 질병의 예방, 개선 또는 건강의 회복 등과 관련된 기능을 수행할 수 있는 것을 의미한다.The above-mentioned “health functional food” refers to a food manufactured or processed using specific ingredients as raw materials or by extracting, concentrating, refining, or mixing specific ingredients contained in the raw materials for the purpose of health supplementation. It refers to food designed and processed to fully exert bioregulatory functions, such as defense, on the living body, and can perform functions related to disease prevention, improvement, or health recovery.
본 개시에 따른 추출물들이 사용될 수 있는 건강기능식품의 종류에는 특별한 제한이 없다. 예컨대, 라면, 기타 면류, 음료수, 차, 드링크제, 알콜 음료, 각종 스프, 육류, 소세지, 빵, 초코렛, 캔디류, 과자류, 피자, 껌류, 아이스크림류를 포함한 낙농제품, 또는 비타민 복합제 등이 있다. 또한, 상기 건강기능식품은 분말, 과립, 정제, 캡슐 또는 음료인 형태를 포함하며, 바람직하게는 음료의 형태를 포함한다. 또한, 본 개시에 따른 추출물들을 건강기능식품으로 사용하는 경우, 이를 그대로 첨가하거나 다른 식품 또는 식품 성분과 함께 사용될 수 있고, 이는 필요에 따라 선택하여 적절하게 사용될 수 있다. 또한, 본 개시에 따른 추출물들 이외에 통상의 기술자의 선택에 따라 통상적으로 건강기능식품에 함유될 수 있는 적절한 기타 보조성분과 공지의 첨가제를 혼합할 수 있다.There is no particular limitation on the types of health functional foods in which the extracts according to the present disclosure can be used. For example, ramen, other noodles, beverages, tea, drinks, alcoholic beverages, various soups, meat, sausages, bread, chocolate, candy, confectionery, pizza, gum, dairy products including ice cream, or vitamin complexes. In addition, the health functional food includes powder, granule, tablet, capsule or beverage form, and preferably includes the form of beverage. In addition, when using the extracts according to the present disclosure as health functional foods, they can be added as is or used together with other foods or food ingredients, and can be selected and used appropriately as needed. In addition, in addition to the extracts according to the present disclosure, other appropriate auxiliary ingredients and known additives that can be commonly contained in health functional foods can be mixed according to the selection of a person skilled in the art.
{실시예}{Example}
이하, 본 개시를 실시예에 의하여 상세히 설명한다. 다만, 하기 실시예는 본 개시의 전반적인 이해를 돕기 위한 예시일 뿐, 본 개시의 내용이 하기 실시예에 한정되는 것은 아니다.Hereinafter, the present disclosure will be described in detail through examples. However, the following examples are merely examples to aid the overall understanding of the present disclosure, and the content of the present disclosure is not limited to the following examples.
<제조예> 도라지청의 제조<Production example> Production of bellflower root
1. 실시예 11. Example 1
3년근 우량 약도라지를 세척한 후, 0.1~0.5 cm 크기로 슬라이스하였다. 정제수에 상기 슬라이스된 도라지 100 중량부에 대하여 쌀조청을 20 중량부를 혼합하여(도라지 및 쌀조청의 중량비는 5 : 1), 도라지 혼합물을 얻었다. 이어서, 상기 도라지 혼합물에 셀룰라아제(cellulase) 및 폴리갈락투로나아제(polygalacturonase)를 처리하고, 쌀조청 100 중량부에 대하여 쌀누룩균 0.3 중량부를 접종하여(쌀조청 및 쌀누룩균의 중량비는 100 : 0.3), 37℃에서 23시간 동안 정치배양하여 발효함으로써 도라지 발효물을 얻었다. 상기 도라지 발효물을 여과하여 고액 분리하고, 45℃의 온도로 가열하여 농축하여, 도라지청을 제조하였다.After washing the 3-year-old superior herbal bellflower root, it was sliced into 0.1-0.5 cm pieces. 20 parts by weight of rice syrup was mixed with purified water for 100 parts by weight of the sliced bellflower root (the weight ratio of bellflower root and rice syrup was 5:1) to obtain a balloon flower mixture. Next, the bellflower mixture was treated with cellulase and polygalacturonase, and 0.3 parts by weight of rice malt bacteria were inoculated with respect to 100 parts by weight of rice syrup (the weight ratio of rice syrup and rice malt bacteria was 100:0.3). ), fermented bellflower root was obtained by fermentation by static cultivation at 37°C for 23 hours. The bellflower fermented product was filtered to separate solid and liquid, heated to a temperature of 45°C and concentrated, and bellflower root was prepared.
2. 실시예 22. Example 2
쌀누룩균이 아닌 플라보박테리움을 사용한 것을 제외하고는 실시예 1과 동일한 방법으로 도라지청을 제조하였다.Bellflower root was prepared in the same manner as in Example 1, except that Flavobacterium rather than rice malt fungus was used.
3. 비교예 13. Comparative Example 1
쌀누룩균이 아닌 유산균을 사용한 것을 제외하고는 실시예 1과 동일한 방법으로 도라지청을 제조하였다.Bellflower root was prepared in the same manner as Example 1, except that lactic acid bacteria rather than rice malt bacteria were used.
4. 비교예 24. Comparative Example 2
도라지 혼합물을 얻는 단계에서, 도라지 및 쌀조청의 중량비가 1 : 1인 것을 제외하고는 실시예 1과 동일한 방법으로 도라지청을 제조하였다.In the step of obtaining the balloon flower mixture, bellflower root syrup was prepared in the same manner as in Example 1, except that the weight ratio of bellflower root and rice syrup was 1:1.
5. 비교예 35. Comparative Example 3
도라지 혼합물을 얻는 단계에서, 도라지 및 쌀조청의 중량비가 15 : 1인 것을 제외하고는 실시예 1과 동일한 방법으로 도라지청을 제조하였다.In the step of obtaining the balloon flower mixture, bellflower root syrup was prepared in the same manner as in Example 1, except that the weight ratio of bellflower root and rice syrup was 15:1.
6. 비교예 46. Comparative Example 4
도라지 발효물을 얻는 단계에서, 쌀조청 및 쌀누룩균의 중량비가 100 : 0.01인 것을 제외하고는 실시예 1과 동일한 방법으로 도라지청을 제조하였다.In the step of obtaining the bellflower fermented product, bellflower root was prepared in the same manner as in Example 1, except that the weight ratio of rice syrup and rice malt bacteria was 100:0.01.
7. 비교예 57. Comparative Example 5
도라지 발효물을 얻는 단계에서, 쌀조청 및 쌀누룩균의 중량비가 100 : 1인 것을 제외하고는 실시예 1과 동일한 방법으로 도라지청을 제조하였다.In the step of obtaining the fermented bellflower root, bellflower root syrup was prepared in the same manner as in Example 1, except that the weight ratio of rice syrup and rice malt bacteria was 100:1.
<실험예 1> 도라지청의 당도 평가<Experimental Example 1> Evaluation of sweetness of bellflower root
제조예에서 제조된 도라지청의 당도를 평가하였다. 당도 검사 결과의 단위는 브릭스(Brix)이다. 그 결과를 표 1에 나타내었다. The sweetness of bellflower root prepared in the preparation example was evaluated. The unit of sugar content test results is Brix. The results are shown in Table 1.
상기 표 1로부터, 본 발명에 따른 도라지청만이 최적의 당도 범위를 만족하는 것을 확인할 수 있다.From Table 1 above, it can be seen that only bellflower root according to the present invention satisfies the optimal sweetness range.
<실험예 2> 도라지청의 당도 평가<Experimental Example 2> Evaluation of sweetness of bellflower root
제조예에서 제조된 도라지청의 점도를 평가하였다. 점도는 점도계를 이용하여 측정하였다. 점도 검사 결과의 단위는 푸아즈(poise)이다. 그 결과를 표 2에 나타내었다.The viscosity of bellflower root prepared in the production example was evaluated. Viscosity was measured using a viscometer. The unit of viscosity test results is poise. The results are shown in Table 2.
상기 표 2로부터, 본 발명에 따른 도라지청만이 최적의 점도 범위를 만족하는 것을 확인할 수 있다.From Table 2 above, it can be seen that only bellflower root according to the present invention satisfies the optimal viscosity range.
<실험예 3> 유효성분의 함량 평가<Experimental Example 3> Evaluation of the content of active ingredients
제조예에서 제조된 도라지청의 플라티코딘 D 함량을 평가하였다. 플라티코딘 D 함량은 HPLC 분석을 통하여 측정하였다. 그 결과를 표 3에 나타내었다.The platycodin D content of bellflower root prepared in the preparation example was evaluated. Platicodin D content was measured through HPLC analysis. The results are shown in Table 3.
상기 표 3으로부터, 본 발명에 따른 도라지청의 유효성분 함량이 높은 것을 알 수 있다.From Table 3, it can be seen that the active ingredient content of bellflower root according to the present invention is high.
<실험예 4> 관능 평가<Experimental Example 4> Sensory evaluation
제조예에서 제조된 도라지청에 대하여 관능 평가를 수행하였다. 패널은 성인 50 명을 선정하여 맛, 향, 전체적 기호도 등을 7점 척도법에 의해 평가하도록 하였다(1=매우 나쁨, 7=매우 좋음) 각 항목에 대한 점수의 평균값으로 관능 평가의 결과를 나타내었다. 그 결과를 표 4에 나타내었다.Sensory evaluation was performed on the bellflower root prepared in the preparation example. The panel selected 50 adults and had them evaluate taste, aroma, and overall preference using a 7-point scale (1=very bad, 7=very good). The results of the sensory evaluation were expressed as the average of the scores for each item. . The results are shown in Table 4.
상기 표 4로부터, 본 발명에 따른 도라지청의 쓴맛 또는 아린 맛이 저감되며, 전체적인 기호도가 우수한 것을 알 수 있다.From Table 4 above, it can be seen that the bitter or sour taste of bellflower root according to the present invention is reduced, and the overall preference is excellent.
본 발명이 상기 언급된 바람직한 실시예와 관련하여 설명되었지만, 발명의 요지와 범위로부터 벗어남이 없이 다양한 수정이나 변형을 하는 것이 가능하다. 따라서 첨부된 청구범위에는 본 발명의 요지에 속하는 한 이러한 수정이나 변형이 포함될 것이다.Although the present invention has been described in connection with the above-mentioned preferred embodiments, various modifications and variations can be made without departing from the spirit and scope of the invention. Accordingly, the appended claims will include such modifications and variations as long as they fall within the spirit of the present invention.
Claims (3)
도라지 및 쌀조청을 혼합하여 도라지 혼합물을 얻는 단계;
상기 도라지 혼합물에 효소를 처리하고 균을 접종하여 발효함으로써 도라지 발효물을 얻는 단계; 및
상기 도라지 발효물을 여과 및 농축하여 당 함량과 점도를 증가시키는 단계;를 포함하며,
상기 도라지 및 쌀조청은 2 내지 10 : 1의 중량비로 혼합되며,
상기 효소는 셀룰라아제(cellulase) 및 폴리갈락투로나아제(polygalacturonase)이며,
상기 균은 쌀누룩균 또는 플라보박테리움(Flavobacterium)인, 플라티코딘 D 함량이 증가된 도라지청을 포함하는 식품 조성물의 제조 방법.A method for producing a food composition containing bellflower root with increased platycodin D content,
Obtaining a balloon flower mixture by mixing bellflower root and rice syrup;
Obtaining a fermented bellflower product by treating the bellflower mixture with an enzyme, inoculating it with bacteria, and fermenting it; and
It includes filtering and concentrating the bellflower fermented product to increase sugar content and viscosity,
The bellflower root and rice syrup are mixed at a weight ratio of 2 to 10:1,
The enzymes are cellulase and polygalacturonase,
A method of producing a food composition containing bellflower root with increased platycodin D content, wherein the bacteria is rice malt or Flavobacterium.
상기 쌀조청 및 균은 100 : 0.1 내지 0.5의 중량비로 혼합되는, 식품 조성물의 제조 방법.According to paragraph 1,
A method for producing a food composition, wherein the rice syrup and bacteria are mixed at a weight ratio of 100:0.1 to 0.5.
상기 도라지청에 함유된 플라티코딘 D를 유효성분으로 포함하며,
40 내지 70 Brix의 당도 및 500 내지 2000 poise의 점도를 갖는, 식품 조성물.Manufactured by the manufacturing method of paragraph 1 or 2,
Contains platycodin D contained in the bellflower root as an active ingredient,
A food composition having a sugar content of 40 to 70 Brix and a viscosity of 500 to 2000 poise.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020230102756A KR102595524B1 (en) | 2023-08-07 | 2023-08-07 | Platycodon grandiflorum fermented product comprising platycodon grandiflorum and rice grain syrup and method for preparing thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020230102756A KR102595524B1 (en) | 2023-08-07 | 2023-08-07 | Platycodon grandiflorum fermented product comprising platycodon grandiflorum and rice grain syrup and method for preparing thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102595524B1 true KR102595524B1 (en) | 2023-10-30 |
Family
ID=88557880
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020230102756A KR102595524B1 (en) | 2023-08-07 | 2023-08-07 | Platycodon grandiflorum fermented product comprising platycodon grandiflorum and rice grain syrup and method for preparing thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102595524B1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20130011013A (en) * | 2011-07-20 | 2013-01-30 | 주식회사 바이오랜드 | Manufacturing methods of fermentation bellflower increased aneffective ingredient |
KR101516063B1 (en) | 2013-01-29 | 2015-05-04 | 연세대학교 원주산학협력단 | Skin moisturizing composition comprising Platycodin grandiflorum containing platycodin D |
KR20200073857A (en) * | 2018-12-14 | 2020-06-24 | 대한민국(농촌진흥청장) | Method for increasing platycodin E content in Platycodon grandiflorum using Aspergillus awamori |
KR20200080929A (en) * | 2018-12-27 | 2020-07-07 | 산촌마을농업회사법인유한회사 | Production method of belloflower syrup |
KR20210069319A (en) * | 2019-12-03 | 2021-06-11 | 농업회사법인(주)가고파힐링푸드 | Method for manufacturing balloon flower root concentrate |
KR20220025680A (en) * | 2020-08-24 | 2022-03-03 | (주)케비젠 | Method for producing fermented balloon flower postbiotics with increased effective component content using lactic acid bacteria |
-
2023
- 2023-08-07 KR KR1020230102756A patent/KR102595524B1/en active IP Right Grant
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20130011013A (en) * | 2011-07-20 | 2013-01-30 | 주식회사 바이오랜드 | Manufacturing methods of fermentation bellflower increased aneffective ingredient |
KR101516063B1 (en) | 2013-01-29 | 2015-05-04 | 연세대학교 원주산학협력단 | Skin moisturizing composition comprising Platycodin grandiflorum containing platycodin D |
KR20200073857A (en) * | 2018-12-14 | 2020-06-24 | 대한민국(농촌진흥청장) | Method for increasing platycodin E content in Platycodon grandiflorum using Aspergillus awamori |
KR20200080929A (en) * | 2018-12-27 | 2020-07-07 | 산촌마을농업회사법인유한회사 | Production method of belloflower syrup |
KR20210069319A (en) * | 2019-12-03 | 2021-06-11 | 농업회사법인(주)가고파힐링푸드 | Method for manufacturing balloon flower root concentrate |
KR20220025680A (en) * | 2020-08-24 | 2022-03-03 | (주)케비젠 | Method for producing fermented balloon flower postbiotics with increased effective component content using lactic acid bacteria |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101130741B (en) | Vinegar koji and biological edible vinegar, and method of producing the same | |
KR101260466B1 (en) | Preparation method for mother chrysanthemum vinegar | |
CN104630010B (en) | Tonic health preserving wine and preparation method thereof | |
CN102888328A (en) | Passion fruit wine and production method thereof | |
KR101472546B1 (en) | Beverage comprising extract of fermented Curcuma long L. and manufacturing method thereof | |
KR20200084212A (en) | Anti-obesity composition comprising extract of Sargassum horneri | |
CN112048404A (en) | Trollflower-sea buckthorn compound wheat beer and brewing method thereof | |
KR102225182B1 (en) | Freeze-dryed Makkoli and preparation method of the same | |
CN110607218B (en) | Sobering-up vinegar and preparation method and application thereof | |
KR102168192B1 (en) | Healthful mixed tea development using fermented herbs, fruits and shiitake | |
CN107904071A (en) | A kind of processing method of shatian pomelo | |
KR101673204B1 (en) | Health beverage using natural materials with protection of brain cells | |
KR102595524B1 (en) | Platycodon grandiflorum fermented product comprising platycodon grandiflorum and rice grain syrup and method for preparing thereof | |
EP1968401B1 (en) | Functional food composition for treating allergy, natural tea using the same and the manufacturing method thereof | |
KR20100102890A (en) | Process of manufacture of ability drink that use medicinal plant extraction liquid | |
Ma et al. | Nutritional value and processing technology of mulberry fruit products | |
KR20190111592A (en) | Food Composition Comprising Polygonum Cuspidatum and Noble Preparation Method thereof | |
CN114452357A (en) | Liupao tea-containing preparation with blood fat and blood sugar reducing effects and preparation method thereof | |
KR20170037352A (en) | Liquid Red ginseng tea and Method of producing thereof | |
KR101807832B1 (en) | A beverage composition for removing hangover comprising cudrania tricuspidata extracts | |
KR101093193B1 (en) | Method for manufacturing jujube beverage using enzyme resolving | |
KR102211759B1 (en) | Health-promoting sphere comprising cacao nibs and preparation method thereof | |
KR102627679B1 (en) | Manufacturing method of Beverage containing Vitis vinifera and Blueberry | |
KR102201601B1 (en) | The balloonflower syrup bloomed | |
KR102452260B1 (en) | Method for producing jelly beverage for child using Gastrodia elata |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |